gene set enrichment analysis (gsea – java implementation) Search Results


90
Broad Institute Inc gene set enrichment analysis command line
(A) <t>GSEA</t> analysis showing Hallmark gene sets significantly differentially enriched (padj<0.05 and -1.5<Normalized enrichment score (NES) or NES>1.5) in WT-LPS vs WT (left) and/or in Tet2 -/- -LPS vs Tet2 -/- (right) comparisons. (B-E) Enrichment plots for E2F TARGETS (B-C) and TNF-α signalling via NF-κB (D-E) hallmark genesets in WT-LPS vs WT (B,D) and Tet2 -/- -LPS vs Tet2 -/- (C,E) conditions. NES: normalized enrichment score. (F-G) violin plot representing TE subfamilies expression for each TE subfamily significantly (p<0.05) differentially expressed in WT-LPS vs WT (F) and Tet2 -/- -LPS vs Tet2 -/- (G) conditions.
Gene Set Enrichment Analysis Command Line, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene+set+enrichment+analysis+(gsea+%E2%80%93+java+implementation)/gene+set+enrichment+analysis+command+line/bio_rxiv__2025__07__21__665900-227-9-21
Average 90 stars, based on 1 article reviews
gene set enrichment analysis command line - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Broad Institute Inc gsea software
(A) <t>GSEA</t> analysis showing Hallmark gene sets significantly differentially enriched (padj<0.05 and -1.5<Normalized enrichment score (NES) or NES>1.5) in WT-LPS vs WT (left) and/or in Tet2 -/- -LPS vs Tet2 -/- (right) comparisons. (B-E) Enrichment plots for E2F TARGETS (B-C) and TNF-α signalling via NF-κB (D-E) hallmark genesets in WT-LPS vs WT (B,D) and Tet2 -/- -LPS vs Tet2 -/- (C,E) conditions. NES: normalized enrichment score. (F-G) violin plot representing TE subfamilies expression for each TE subfamily significantly (p<0.05) differentially expressed in WT-LPS vs WT (F) and Tet2 -/- -LPS vs Tet2 -/- (G) conditions.
Gsea Software, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene+set+enrichment+analysis+(gsea+%E2%80%93+java+implementation)/gsea+software/pm26880268-51-33-37
Average 90 stars, based on 1 article reviews
gsea software - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Broad Institute Inc gsea
(A) <t>GSEA</t> analysis showing Hallmark gene sets significantly differentially enriched (padj<0.05 and -1.5<Normalized enrichment score (NES) or NES>1.5) in WT-LPS vs WT (left) and/or in Tet2 -/- -LPS vs Tet2 -/- (right) comparisons. (B-E) Enrichment plots for E2F TARGETS (B-C) and TNF-α signalling via NF-κB (D-E) hallmark genesets in WT-LPS vs WT (B,D) and Tet2 -/- -LPS vs Tet2 -/- (C,E) conditions. NES: normalized enrichment score. (F-G) violin plot representing TE subfamilies expression for each TE subfamily significantly (p<0.05) differentially expressed in WT-LPS vs WT (F) and Tet2 -/- -LPS vs Tet2 -/- (G) conditions.
Gsea, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene+set+enrichment+analysis+(gsea+%E2%80%93+java+implementation)/gsea/pm26781069-71-0-5
Average 90 stars, based on 1 article reviews
gsea - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Broad Institute Inc gene set enrichment analysis (gsea) software
(A) <t>GSEA</t> analysis showing Hallmark gene sets significantly differentially enriched (padj<0.05 and -1.5<Normalized enrichment score (NES) or NES>1.5) in WT-LPS vs WT (left) and/or in Tet2 -/- -LPS vs Tet2 -/- (right) comparisons. (B-E) Enrichment plots for E2F TARGETS (B-C) and TNF-α signalling via NF-κB (D-E) hallmark genesets in WT-LPS vs WT (B,D) and Tet2 -/- -LPS vs Tet2 -/- (C,E) conditions. NES: normalized enrichment score. (F-G) violin plot representing TE subfamilies expression for each TE subfamily significantly (p<0.05) differentially expressed in WT-LPS vs WT (F) and Tet2 -/- -LPS vs Tet2 -/- (G) conditions.
Gene Set Enrichment Analysis (Gsea) Software, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene+set+enrichment+analysis+(gsea+%E2%80%93+java+implementation)/gene+set+enrichment+analysis++gsea+/pm27694322-63-16-24
Average 90 stars, based on 1 article reviews
gene set enrichment analysis (gsea) software - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Broad Institute Inc gene set enrichment (gsea)
(A) <t>GSEA</t> analysis showing Hallmark gene sets significantly differentially enriched (padj<0.05 and -1.5<Normalized enrichment score (NES) or NES>1.5) in WT-LPS vs WT (left) and/or in Tet2 -/- -LPS vs Tet2 -/- (right) comparisons. (B-E) Enrichment plots for E2F TARGETS (B-C) and TNF-α signalling via NF-κB (D-E) hallmark genesets in WT-LPS vs WT (B,D) and Tet2 -/- -LPS vs Tet2 -/- (C,E) conditions. NES: normalized enrichment score. (F-G) violin plot representing TE subfamilies expression for each TE subfamily significantly (p<0.05) differentially expressed in WT-LPS vs WT (F) and Tet2 -/- -LPS vs Tet2 -/- (G) conditions.
Gene Set Enrichment (Gsea), supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene+set+enrichment+analysis+(gsea+%E2%80%93+java+implementation)/gene+set+enrichment+analysis+software/pm25409149-367-9-13
Average 90 stars, based on 1 article reviews
gene set enrichment (gsea) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Broad Institute Inc gsea module
(A) <t>GSEA</t> analysis showing Hallmark gene sets significantly differentially enriched (padj<0.05 and -1.5<Normalized enrichment score (NES) or NES>1.5) in WT-LPS vs WT (left) and/or in Tet2 -/- -LPS vs Tet2 -/- (right) comparisons. (B-E) Enrichment plots for E2F TARGETS (B-C) and TNF-α signalling via NF-κB (D-E) hallmark genesets in WT-LPS vs WT (B,D) and Tet2 -/- -LPS vs Tet2 -/- (C,E) conditions. NES: normalized enrichment score. (F-G) violin plot representing TE subfamilies expression for each TE subfamily significantly (p<0.05) differentially expressed in WT-LPS vs WT (F) and Tet2 -/- -LPS vs Tet2 -/- (G) conditions.
Gsea Module, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene+set+enrichment+analysis+(gsea+%E2%80%93+java+implementation)/gsea+module/pm29132323-90-11-15
Average 90 stars, based on 1 article reviews
gsea module - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Broad Institute Inc pre-ranked gsea module software
RNA sequencing results (GEO dataset GSE94415) of KRAS G12D ;Trp53f / f mesothelioma (KPM) cells ( n = 3) compared with pleural mesothelial cells (PMC; n = 1 pooled triplicate). n denotes biological replicates, since pooled triplicate technical replicates from each cell line were sequenced. Unsupervised hierarchical clustering shows distinctive gene expression of KPM versus PMC. Volcano plot showing some top KPM versus PMC differentially expressed genes. KPM and PMC expression of classic mesothelioma markers (top) and top KPM versus PMC overexpressed genes (bottom). Gene set enrichment analysis, including enrichment score and nominal probability value of the 150 gene‐signature specifically over‐represented in human mesothelioma compared with other thoracic malignancies derived from 113 patients (GSE42977) within the transcriptome of KPM cells versus PMC shows significant enrichment of the human mesothelioma signature in KPM cells. Data information: In (C), data are presented as mean (columns) and 95% confidence interval (bars). P : probability, two‐way ANOVA. ns, *, **, and ***: P > 0.05, P < 0.05, P < 0.01, and P < 0.001, respectively, compared with PMC, Bonferroni post‐tests. Source data are available online for this figure.
Pre Ranked Gsea Module Software, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene+set+enrichment+analysis+(gsea+%E2%80%93+java+implementation)/pre+ranked+gsea+module+software/pmc08819314-148-12-9
Average 90 stars, based on 1 article reviews
pre-ranked gsea module software - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Broad Institute Inc gsea platform
RNA sequencing results (GEO dataset GSE94415) of KRAS G12D ;Trp53f / f mesothelioma (KPM) cells ( n = 3) compared with pleural mesothelial cells (PMC; n = 1 pooled triplicate). n denotes biological replicates, since pooled triplicate technical replicates from each cell line were sequenced. Unsupervised hierarchical clustering shows distinctive gene expression of KPM versus PMC. Volcano plot showing some top KPM versus PMC differentially expressed genes. KPM and PMC expression of classic mesothelioma markers (top) and top KPM versus PMC overexpressed genes (bottom). Gene set enrichment analysis, including enrichment score and nominal probability value of the 150 gene‐signature specifically over‐represented in human mesothelioma compared with other thoracic malignancies derived from 113 patients (GSE42977) within the transcriptome of KPM cells versus PMC shows significant enrichment of the human mesothelioma signature in KPM cells. Data information: In (C), data are presented as mean (columns) and 95% confidence interval (bars). P : probability, two‐way ANOVA. ns, *, **, and ***: P > 0.05, P < 0.05, P < 0.01, and P < 0.001, respectively, compared with PMC, Bonferroni post‐tests. Source data are available online for this figure.
Gsea Platform, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene+set+enrichment+analysis+(gsea+%E2%80%93+java+implementation)/gsea+platform/pmc04764075-82-9-12
Average 90 stars, based on 1 article reviews
gsea platform - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Broad Institute Inc gsea software msigdbv6
RNA sequencing results (GEO dataset GSE94415) of KRAS G12D ;Trp53f / f mesothelioma (KPM) cells ( n = 3) compared with pleural mesothelial cells (PMC; n = 1 pooled triplicate). n denotes biological replicates, since pooled triplicate technical replicates from each cell line were sequenced. Unsupervised hierarchical clustering shows distinctive gene expression of KPM versus PMC. Volcano plot showing some top KPM versus PMC differentially expressed genes. KPM and PMC expression of classic mesothelioma markers (top) and top KPM versus PMC overexpressed genes (bottom). Gene set enrichment analysis, including enrichment score and nominal probability value of the 150 gene‐signature specifically over‐represented in human mesothelioma compared with other thoracic malignancies derived from 113 patients (GSE42977) within the transcriptome of KPM cells versus PMC shows significant enrichment of the human mesothelioma signature in KPM cells. Data information: In (C), data are presented as mean (columns) and 95% confidence interval (bars). P : probability, two‐way ANOVA. ns, *, **, and ***: P > 0.05, P < 0.05, P < 0.01, and P < 0.001, respectively, compared with PMC, Bonferroni post‐tests. Source data are available online for this figure.
Gsea Software Msigdbv6, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene+set+enrichment+analysis+(gsea+%E2%80%93+java+implementation)/gsea+database/pmc08411121__mmc3-745-8-11
Average 90 stars, based on 1 article reviews
gsea software msigdbv6 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
InContext Inc gsea-incontext
RNA sequencing results (GEO dataset GSE94415) of KRAS G12D ;Trp53f / f mesothelioma (KPM) cells ( n = 3) compared with pleural mesothelial cells (PMC; n = 1 pooled triplicate). n denotes biological replicates, since pooled triplicate technical replicates from each cell line were sequenced. Unsupervised hierarchical clustering shows distinctive gene expression of KPM versus PMC. Volcano plot showing some top KPM versus PMC differentially expressed genes. KPM and PMC expression of classic mesothelioma markers (top) and top KPM versus PMC overexpressed genes (bottom). Gene set enrichment analysis, including enrichment score and nominal probability value of the 150 gene‐signature specifically over‐represented in human mesothelioma compared with other thoracic malignancies derived from 113 patients (GSE42977) within the transcriptome of KPM cells versus PMC shows significant enrichment of the human mesothelioma signature in KPM cells. Data information: In (C), data are presented as mean (columns) and 95% confidence interval (bars). P : probability, two‐way ANOVA. ns, *, **, and ***: P > 0.05, P < 0.05, P < 0.01, and P < 0.001, respectively, compared with PMC, Bonferroni post‐tests. Source data are available online for this figure.
Gsea Incontext, supplied by InContext Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene+set+enrichment+analysis+(gsea+%E2%80%93+java+implementation)/gsea+incontext/ppr0761366-165-9-12
Average 90 stars, based on 1 article reviews
gsea-incontext - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
GeneGo Inc gene set enrichment analysis (gsea) algorithms
RNA sequencing results (GEO dataset GSE94415) of KRAS G12D ;Trp53f / f mesothelioma (KPM) cells ( n = 3) compared with pleural mesothelial cells (PMC; n = 1 pooled triplicate). n denotes biological replicates, since pooled triplicate technical replicates from each cell line were sequenced. Unsupervised hierarchical clustering shows distinctive gene expression of KPM versus PMC. Volcano plot showing some top KPM versus PMC differentially expressed genes. KPM and PMC expression of classic mesothelioma markers (top) and top KPM versus PMC overexpressed genes (bottom). Gene set enrichment analysis, including enrichment score and nominal probability value of the 150 gene‐signature specifically over‐represented in human mesothelioma compared with other thoracic malignancies derived from 113 patients (GSE42977) within the transcriptome of KPM cells versus PMC shows significant enrichment of the human mesothelioma signature in KPM cells. Data information: In (C), data are presented as mean (columns) and 95% confidence interval (bars). P : probability, two‐way ANOVA. ns, *, **, and ***: P > 0.05, P < 0.05, P < 0.01, and P < 0.001, respectively, compared with PMC, Bonferroni post‐tests. Source data are available online for this figure.
Gene Set Enrichment Analysis (Gsea) Algorithms, supplied by GeneGo Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene+set+enrichment+analysis+(gsea+%E2%80%93+java+implementation)/gene+set+enrichment+analysis/10__1515_slash_jib___2012___194-25-16-37
Average 90 stars, based on 1 article reviews
gene set enrichment analysis (gsea) algorithms - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Broad Institute Inc gsea preranked tool
Selective restoration of WT p53 transcriptional responses by PC14586 in cells. A, Quantification of CDKN1A (p21) and MDM2 mRNA by qRT-PCR in p53-Y220C, other p53 hotspot mutants, p53 WT, and p53 KO cell lysates following 5 hours of treatment with rezatapopt (PC14586). Data for the top four cell lines were representative results of three biological repeats, data for other cell lines were from two biological repeats, and graphs were plotted as mean ± SD. A.U., arbitrary unit. B, Scatter plots showing expression levels of genes involved in the p53 signaling pathway in cells following treatment with rezatapopt (PC14586). RNA samples extracted from p53-Y220C–expressing cells (NUGC-3), p53 KO cells (NUGC-3 KO) treated with rezatapopt (PC14586; 5 µmol/L, 16 hours), and NUGC-3 KO_p53i cells induced with doxycycline (50 ng/mL, 12.5 hours) were profiled by the Qiagen RT 2 p53 pathway qRT-PCR panel. Scales are in log 10 (relative expression to housekeeping genes; n = 3). C, Scatter plots of log 2 (transcripts per million + 0.01) and volcano plots of −log 10 (FDR) versus log 2 (fold change) from RNA-seq analysis of expressed genes from p53-Y220C and p53 KO cell lines following DMSO and rezatapopt (PC14586; 5 µmol/L) treatment (16 hours). Genes enriched in gene sets of Fischer direct p53 targets (upregulated), Fischer DREAM Targets (downregulated), DEGs excluding the above-enriched genes (upregulated and downregulated), and non-DEGs were sequentially overlaid as indicated. D, Top enriched gene sets from <t>GSEA</t> of the Molecular Signatures Database C2 collection curated gene sets in the indicated RNA-seq data (NUGC-3 treated with 5 µmol/L PC14586 versus DMSO for 16 hours) from DEGs (Walden stat <t>preranked).</t> The number of overlapping genes from the upregulated DEGs enriched in both the Fischer direct p53 targets gene set, and each listed gene set was divided by the total number of genes in each listed gene set and then multiplied by 100 to obtain the overlap with Fischer_Direct_p53_Targets (%). Overlap with Fischer DREAM targets (%) was calculated in a similar manner, except using the downregulated DEGs. To calculate enrichment (%), the number of genes from the DEGs with the indicated direction of regulation enriched in each gene set was divided by the total number of genes in each listed gene set and multiplied by 100. Normalized enrichment scores (NES) and percentages (%) were plotted on the upper and lower x -axes. All gene sets shown had enrichment of FDR q value ( q ) <0.001. Note that the names of gene sets were shortened. See Supplementary File S11 for details. E, Examples of the GSEA enrichment plots from D . F, Schematic representation of p53 in the transcriptional repression of cell-cycle genes via retinoblastoma-E2F and DREAM complexes. CDK, cyclin-dependent kinase; RBL, retinoblastoma-like proteins p107 (RBL1) and p130 (RBL2).
Gsea Preranked Tool, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene+set+enrichment+analysis+(gsea+%E2%80%93+java+implementation)/gseapreranked+tool/pmc12130801-395-11-17
Average 90 stars, based on 1 article reviews
gsea preranked tool - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


(A) GSEA analysis showing Hallmark gene sets significantly differentially enriched (padj<0.05 and -1.5<Normalized enrichment score (NES) or NES>1.5) in WT-LPS vs WT (left) and/or in Tet2 -/- -LPS vs Tet2 -/- (right) comparisons. (B-E) Enrichment plots for E2F TARGETS (B-C) and TNF-α signalling via NF-κB (D-E) hallmark genesets in WT-LPS vs WT (B,D) and Tet2 -/- -LPS vs Tet2 -/- (C,E) conditions. NES: normalized enrichment score. (F-G) violin plot representing TE subfamilies expression for each TE subfamily significantly (p<0.05) differentially expressed in WT-LPS vs WT (F) and Tet2 -/- -LPS vs Tet2 -/- (G) conditions.

Journal: bioRxiv

Article Title: Differential sensitivity to LINE 1-induced damage contributes to the expansion of Tet2-deficient HSCs upon chronic inflammatory stress

doi: 10.1101/2025.07.21.665900

Figure Lengend Snippet: (A) GSEA analysis showing Hallmark gene sets significantly differentially enriched (padj<0.05 and -1.51.5) in WT-LPS vs WT (left) and/or in Tet2 -/- -LPS vs Tet2 -/- (right) comparisons. (B-E) Enrichment plots for E2F TARGETS (B-C) and TNF-α signalling via NF-κB (D-E) hallmark genesets in WT-LPS vs WT (B,D) and Tet2 -/- -LPS vs Tet2 -/- (C,E) conditions. NES: normalized enrichment score. (F-G) violin plot representing TE subfamilies expression for each TE subfamily significantly (p<0.05) differentially expressed in WT-LPS vs WT (F) and Tet2 -/- -LPS vs Tet2 -/- (G) conditions.

Article Snippet: For pathway enrichment analysis and data visualization, we performed Gene Set Enrichment Analysis (GSEA) using the GSEA command line (v 4.3.3, Broad Institute) ( ).

Techniques: Expressing

RNA sequencing results (GEO dataset GSE94415) of KRAS G12D ;Trp53f / f mesothelioma (KPM) cells ( n = 3) compared with pleural mesothelial cells (PMC; n = 1 pooled triplicate). n denotes biological replicates, since pooled triplicate technical replicates from each cell line were sequenced. Unsupervised hierarchical clustering shows distinctive gene expression of KPM versus PMC. Volcano plot showing some top KPM versus PMC differentially expressed genes. KPM and PMC expression of classic mesothelioma markers (top) and top KPM versus PMC overexpressed genes (bottom). Gene set enrichment analysis, including enrichment score and nominal probability value of the 150 gene‐signature specifically over‐represented in human mesothelioma compared with other thoracic malignancies derived from 113 patients (GSE42977) within the transcriptome of KPM cells versus PMC shows significant enrichment of the human mesothelioma signature in KPM cells. Data information: In (C), data are presented as mean (columns) and 95% confidence interval (bars). P : probability, two‐way ANOVA. ns, *, **, and ***: P > 0.05, P < 0.05, P < 0.01, and P < 0.001, respectively, compared with PMC, Bonferroni post‐tests. Source data are available online for this figure.

Journal: EMBO Molecular Medicine

Article Title: KRAS signaling in malignant pleural mesothelioma

doi: 10.15252/emmm.202013631

Figure Lengend Snippet: RNA sequencing results (GEO dataset GSE94415) of KRAS G12D ;Trp53f / f mesothelioma (KPM) cells ( n = 3) compared with pleural mesothelial cells (PMC; n = 1 pooled triplicate). n denotes biological replicates, since pooled triplicate technical replicates from each cell line were sequenced. Unsupervised hierarchical clustering shows distinctive gene expression of KPM versus PMC. Volcano plot showing some top KPM versus PMC differentially expressed genes. KPM and PMC expression of classic mesothelioma markers (top) and top KPM versus PMC overexpressed genes (bottom). Gene set enrichment analysis, including enrichment score and nominal probability value of the 150 gene‐signature specifically over‐represented in human mesothelioma compared with other thoracic malignancies derived from 113 patients (GSE42977) within the transcriptome of KPM cells versus PMC shows significant enrichment of the human mesothelioma signature in KPM cells. Data information: In (C), data are presented as mean (columns) and 95% confidence interval (bars). P : probability, two‐way ANOVA. ns, *, **, and ***: P > 0.05, P < 0.05, P < 0.01, and P < 0.001, respectively, compared with PMC, Bonferroni post‐tests. Source data are available online for this figure.

Article Snippet: Gene set enrichment analysis (GSEA) was performed with the Broad Institute pre‐ranked GSEA module software ( http://software.broadinstitute.org/gsea/index.jsp ;Subramanian et al , ).

Techniques: RNA Sequencing, Gene Expression, Expressing, Derivative Assay

Selective restoration of WT p53 transcriptional responses by PC14586 in cells. A, Quantification of CDKN1A (p21) and MDM2 mRNA by qRT-PCR in p53-Y220C, other p53 hotspot mutants, p53 WT, and p53 KO cell lysates following 5 hours of treatment with rezatapopt (PC14586). Data for the top four cell lines were representative results of three biological repeats, data for other cell lines were from two biological repeats, and graphs were plotted as mean ± SD. A.U., arbitrary unit. B, Scatter plots showing expression levels of genes involved in the p53 signaling pathway in cells following treatment with rezatapopt (PC14586). RNA samples extracted from p53-Y220C–expressing cells (NUGC-3), p53 KO cells (NUGC-3 KO) treated with rezatapopt (PC14586; 5 µmol/L, 16 hours), and NUGC-3 KO_p53i cells induced with doxycycline (50 ng/mL, 12.5 hours) were profiled by the Qiagen RT 2 p53 pathway qRT-PCR panel. Scales are in log 10 (relative expression to housekeeping genes; n = 3). C, Scatter plots of log 2 (transcripts per million + 0.01) and volcano plots of −log 10 (FDR) versus log 2 (fold change) from RNA-seq analysis of expressed genes from p53-Y220C and p53 KO cell lines following DMSO and rezatapopt (PC14586; 5 µmol/L) treatment (16 hours). Genes enriched in gene sets of Fischer direct p53 targets (upregulated), Fischer DREAM Targets (downregulated), DEGs excluding the above-enriched genes (upregulated and downregulated), and non-DEGs were sequentially overlaid as indicated. D, Top enriched gene sets from GSEA of the Molecular Signatures Database C2 collection curated gene sets in the indicated RNA-seq data (NUGC-3 treated with 5 µmol/L PC14586 versus DMSO for 16 hours) from DEGs (Walden stat preranked). The number of overlapping genes from the upregulated DEGs enriched in both the Fischer direct p53 targets gene set, and each listed gene set was divided by the total number of genes in each listed gene set and then multiplied by 100 to obtain the overlap with Fischer_Direct_p53_Targets (%). Overlap with Fischer DREAM targets (%) was calculated in a similar manner, except using the downregulated DEGs. To calculate enrichment (%), the number of genes from the DEGs with the indicated direction of regulation enriched in each gene set was divided by the total number of genes in each listed gene set and multiplied by 100. Normalized enrichment scores (NES) and percentages (%) were plotted on the upper and lower x -axes. All gene sets shown had enrichment of FDR q value ( q ) <0.001. Note that the names of gene sets were shortened. See Supplementary File S11 for details. E, Examples of the GSEA enrichment plots from D . F, Schematic representation of p53 in the transcriptional repression of cell-cycle genes via retinoblastoma-E2F and DREAM complexes. CDK, cyclin-dependent kinase; RBL, retinoblastoma-like proteins p107 (RBL1) and p130 (RBL2).

Journal: Cancer Discovery

Article Title: Restoration of the Tumor Suppressor Function of Y220C-Mutant p53 by Rezatapopt, a Small-Molecule Reactivator

doi: 10.1158/2159-8290.CD-24-1421

Figure Lengend Snippet: Selective restoration of WT p53 transcriptional responses by PC14586 in cells. A, Quantification of CDKN1A (p21) and MDM2 mRNA by qRT-PCR in p53-Y220C, other p53 hotspot mutants, p53 WT, and p53 KO cell lysates following 5 hours of treatment with rezatapopt (PC14586). Data for the top four cell lines were representative results of three biological repeats, data for other cell lines were from two biological repeats, and graphs were plotted as mean ± SD. A.U., arbitrary unit. B, Scatter plots showing expression levels of genes involved in the p53 signaling pathway in cells following treatment with rezatapopt (PC14586). RNA samples extracted from p53-Y220C–expressing cells (NUGC-3), p53 KO cells (NUGC-3 KO) treated with rezatapopt (PC14586; 5 µmol/L, 16 hours), and NUGC-3 KO_p53i cells induced with doxycycline (50 ng/mL, 12.5 hours) were profiled by the Qiagen RT 2 p53 pathway qRT-PCR panel. Scales are in log 10 (relative expression to housekeeping genes; n = 3). C, Scatter plots of log 2 (transcripts per million + 0.01) and volcano plots of −log 10 (FDR) versus log 2 (fold change) from RNA-seq analysis of expressed genes from p53-Y220C and p53 KO cell lines following DMSO and rezatapopt (PC14586; 5 µmol/L) treatment (16 hours). Genes enriched in gene sets of Fischer direct p53 targets (upregulated), Fischer DREAM Targets (downregulated), DEGs excluding the above-enriched genes (upregulated and downregulated), and non-DEGs were sequentially overlaid as indicated. D, Top enriched gene sets from GSEA of the Molecular Signatures Database C2 collection curated gene sets in the indicated RNA-seq data (NUGC-3 treated with 5 µmol/L PC14586 versus DMSO for 16 hours) from DEGs (Walden stat preranked). The number of overlapping genes from the upregulated DEGs enriched in both the Fischer direct p53 targets gene set, and each listed gene set was divided by the total number of genes in each listed gene set and then multiplied by 100 to obtain the overlap with Fischer_Direct_p53_Targets (%). Overlap with Fischer DREAM targets (%) was calculated in a similar manner, except using the downregulated DEGs. To calculate enrichment (%), the number of genes from the DEGs with the indicated direction of regulation enriched in each gene set was divided by the total number of genes in each listed gene set and multiplied by 100. Normalized enrichment scores (NES) and percentages (%) were plotted on the upper and lower x -axes. All gene sets shown had enrichment of FDR q value ( q ) <0.001. Note that the names of gene sets were shortened. See Supplementary File S11 for details. E, Examples of the GSEA enrichment plots from D . F, Schematic representation of p53 in the transcriptional repression of cell-cycle genes via retinoblastoma-E2F and DREAM complexes. CDK, cyclin-dependent kinase; RBL, retinoblastoma-like proteins p107 (RBL1) and p130 (RBL2).

Article Snippet: Significant DEGs ranked by Wald stat were further analyzed with the GSEA Preranked tool in GSEA software (Broad Institute, version 4.3.2, build 13, RRID: SCR_003199; refs. , ) using the gene sets from the Molecular Signatures Database C2 (curated gene sets) collection (Broad Institute, version 2023.2, RRID: SCR_016863), supplemented with one gene set of the direct p53-targeted lncRNAs, which contains 86 lncRNAs that are upregulated by p53, each having a recurrent p53-binding site close to its transcription start site ( ).

Techniques: Quantitative RT-PCR, Expressing, RNA Sequencing

PC14586 restored multiple facets of dynamic WT p53 transcriptional responses in vivo . A, Time-dependent effects of PC14586 on gene expression of key p53 targets, CDKN1A , MDM2 , and BIRC5 , with repeat daily administration across 6 days in the NUGC-3 xenograft model. n = 4/group. Error bars show the SEM. The red symbols show plasma concentrations (µmol/L) and are designated on the right y -axis. B, Assessment of a panel of 84 p53 pathway genes measured by qRT-PCR. A representative number of upregulated and downregulated p53 target genes are shown across 6 days of 100 mg/kg PC14586 administration, with the mean value of log 2 (fold change) at each time point shown on the heatmap. See Supplementary File S12 for details. RNA samples extracted from tumor samples, as in A , were profiled by the Qiagen RT 2 p53 pathway qRT-PCR panel as described in the Methods section. Symbols represent the mean log 2 (fold change) for each. C, Volcano plots from RNA-seq analysis of expressed genes from NUGC-3 xenograft tumors following PC14586 (100 mg/kg) and vehicle treatment as indicated. Graphs were plotted as in , except that the p53-targeted lncRNA (upregulated) gene set was overlaid on top of the others. See Supplementary Fig. S5B for the corresponding scatter plots. In B and C, vehicle (consolidated), n = 12 and PC14586, n = 4 for each group, as in and and . D, Top enriched gene sets from GSEA of the Molecular Signatures Database C2 collection curated gene sets supplemented with Fischer p53-targeted lncRNA (86 genes; C2+) in the indicated RNA-seq data [rezatapopt (PC14586) for once daily (QD) ×6 at 24 hours] from DEGs. See Supplementary File S14 for details. Gene sets with a normalized enrichment score (NES) and an FDR q value ( q ) < 0.001 are highlighted in green, 0.001 to 0.05 are highlighted in orange, and 0.05 to 0.06 are highlighted in gray. Graphs were plotted as in . E, Updated schematic representation of p53 in regulating the cell cycle via retinoblastoma-E2F and DREAM complexes. Updated from , the lncRNA component was added to complement p21 in regulating the cell cycle. PINCR, p53-induced noncoding RNA.

Journal: Cancer Discovery

Article Title: Restoration of the Tumor Suppressor Function of Y220C-Mutant p53 by Rezatapopt, a Small-Molecule Reactivator

doi: 10.1158/2159-8290.CD-24-1421

Figure Lengend Snippet: PC14586 restored multiple facets of dynamic WT p53 transcriptional responses in vivo . A, Time-dependent effects of PC14586 on gene expression of key p53 targets, CDKN1A , MDM2 , and BIRC5 , with repeat daily administration across 6 days in the NUGC-3 xenograft model. n = 4/group. Error bars show the SEM. The red symbols show plasma concentrations (µmol/L) and are designated on the right y -axis. B, Assessment of a panel of 84 p53 pathway genes measured by qRT-PCR. A representative number of upregulated and downregulated p53 target genes are shown across 6 days of 100 mg/kg PC14586 administration, with the mean value of log 2 (fold change) at each time point shown on the heatmap. See Supplementary File S12 for details. RNA samples extracted from tumor samples, as in A , were profiled by the Qiagen RT 2 p53 pathway qRT-PCR panel as described in the Methods section. Symbols represent the mean log 2 (fold change) for each. C, Volcano plots from RNA-seq analysis of expressed genes from NUGC-3 xenograft tumors following PC14586 (100 mg/kg) and vehicle treatment as indicated. Graphs were plotted as in , except that the p53-targeted lncRNA (upregulated) gene set was overlaid on top of the others. See Supplementary Fig. S5B for the corresponding scatter plots. In B and C, vehicle (consolidated), n = 12 and PC14586, n = 4 for each group, as in and and . D, Top enriched gene sets from GSEA of the Molecular Signatures Database C2 collection curated gene sets supplemented with Fischer p53-targeted lncRNA (86 genes; C2+) in the indicated RNA-seq data [rezatapopt (PC14586) for once daily (QD) ×6 at 24 hours] from DEGs. See Supplementary File S14 for details. Gene sets with a normalized enrichment score (NES) and an FDR q value ( q ) < 0.001 are highlighted in green, 0.001 to 0.05 are highlighted in orange, and 0.05 to 0.06 are highlighted in gray. Graphs were plotted as in . E, Updated schematic representation of p53 in regulating the cell cycle via retinoblastoma-E2F and DREAM complexes. Updated from , the lncRNA component was added to complement p21 in regulating the cell cycle. PINCR, p53-induced noncoding RNA.

Article Snippet: Significant DEGs ranked by Wald stat were further analyzed with the GSEA Preranked tool in GSEA software (Broad Institute, version 4.3.2, build 13, RRID: SCR_003199; refs. , ) using the gene sets from the Molecular Signatures Database C2 (curated gene sets) collection (Broad Institute, version 2023.2, RRID: SCR_016863), supplemented with one gene set of the direct p53-targeted lncRNAs, which contains 86 lncRNAs that are upregulated by p53, each having a recurrent p53-binding site close to its transcription start site ( ).

Techniques: In Vivo, Gene Expression, Clinical Proteomics, Quantitative RT-PCR, RNA Sequencing